Transition Agreement and ReleaseTransition Agreement and Release • August 16th, 2022 • CONTRAFECT Corp • Pharmaceutical preparations • New York
This Transition Agreement and Release (“Agreement”) is made by and between Cara Cassino, M.D. (“Executive”) and ContraFect Corporation, a Delaware corporation (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”) as of August 14, 2022 (the “Effective Date”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Offer Letter (as defined below).
